Media Thread, page-13025

Hi Ibraz4me,

Many thanks for posting. This is actually what HC should be used for, posts that:
• expand our knowledge of other trials;
• look at what other oncologists are doing, and;
• explore new directions that may even inform IMU's current IP.
Posts like this should attract more TUs because they add to the conversation. Its healthy to share.

As other capable posts have already noted ...
CF33 did not just shrink pancreatic cancer cells, it obliterated them, along with scores of others ... and then again in ...
clinical trials ... with buckets of safety.

It took Yuman about 25-30 years to re-engineer CF33, and IMU has now been progressing this OV for several years.
As Rolly has stated, we are many, many years ahead. Isn't it nice to be racing ahead, at 'the cutting edge'?

Thanks again.